The GABA system in anxiety and depression and its therapeutic potential.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuropharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuropharm.2011.08.040PMID 21889518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of GABA in the pathophysiology and treatment of anxiety disorders.

  2025cited by this paper
• Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder.

  2012cited by this paper
• Roles of glutamate signaling in preclinical and/or mechanistic models of depression.

  2012cited by this paper
• The GABAergic deficit hypothesis of major depressive disorder

  2011influential reference
• The GABAB receptor as a target for antidepressant drug action

  2011influential reference
• Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.

  2011cited by this paper
• Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure.

  2011influential reference
• Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala.

  2011cited by this paper
• Evidence-based pharmacological treatment of generalized anxiety disorder.

  2011cited by this paper
• NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses

  2011cited by this paper
• Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.

  2011cited by this paper
• Amygdala circuitry mediating reversible and bidirectional control of anxiety

  2011cited by this paper
• The rise of a new GABA pharmacology.

  2011cited by this paper
• Antidepressant-like properties of α2-containing GABA(A) receptors.

  2011cited by this paper
• Stuck in a rut: rethinking depression and its treatment.

  2011cited by this paper
• Glutamate Receptor Subtypes Mediating Synaptic Activation of Prefrontal Cortex Neurons: Relevance for Schizophrenia

  2011cited by this paper
• Spatiotemporal specificity of GABAA receptor‐mediated regulation of adult hippocampal neurogenesis

  2011cited by this paper
• A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.

  2011cited by this paper
• Positive Feedback Regulation between γ-Aminobutyric Acid Type A (GABAA) Receptor Signaling and Brain-derived Neurotrophic Factor (BDNF) Release in Developing Neurons*

  2011cited by this paper
• GABAA receptor trafficking-mediated plasticity of inhibitory synapses.

  2011cited by this paper
• Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics

  2010cited by this paper
• Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrin

  2010cited by this paper
• Genetic dissection of an amygdala microcircuit that gates conditioned fear

  2010cited by this paper
• Physiology and Pharmacology of the GABA System: Focus on GABA Receptors

  2010cited by this paper
• Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia

  2010influential reference
• Manifesto for a European anxiety disorders research network.

  2010cited by this paper
• Neural bases for addictive properties of benzodiazepines

  2010cited by this paper
• Encoding of conditioned fear in central amygdala inhibitory circuits

  2010influential reference
• GABAB receptors and depression. Current status.

  2010cited by this paper
• Hippocampal NMDA receptors and anxiety: At the interface between cognition and emotion

  2010cited by this paper
• Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results

  2010cited by this paper
• Reducing Abuse Liability of GABAA/Benzodiazepine Ligands via Selective Partial Agonist Efficacy at α1 and α2/3 Subtypes

  2010cited by this paper
• gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.

  2010influential reference
• Neural computations associated with goal-directed choice.

  2010cited by this paper
• Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats

  2010cited by this paper
• GABA‐A Receptor Modulators: Can they Offer any Improvement over Benzodiazepines in the Treatment of Anxiety Disorders?

  2010cited by this paper
• Neural systems underlying approach and avoidance in anxiety disorders

  2010cited by this paper
• Wnt2 expression and signaling is increased by different classes of antidepressant treatments.

  2010cited by this paper
• A Multicenter, Placebo‐Controlled, Double‐Blind, Randomized Study of Efficacy and Safety of Ocinaplon (DOV 273,547) in Generalized Anxiety Disorder

  2010cited by this paper
• Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

  2010cited by this paper
• The pharmacology of anxiety.

  2010cited by this paper
• A neural switch for active and passive fear.

  2010cited by this paper
• Neuronal circuits of fear extinction

  2010cited by this paper
• Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023.

  2009cited by this paper
• The Modulation of Synaptic GABAA Receptors in the Thalamus by Eszopiclone and Zolpidem

  2009cited by this paper
• Fast Synaptic Subcortical Control of Hippocampal Circuits

  2009cited by this paper
• Eszopiclone and fluoxetine enhance the survival of newborn neurons in the adult rat hippocampus.

  2009cited by this paper
• Functional neuroimaging of reward circuitry responsivity to monetary gains and losses in posttraumatic stress disorder.

  2009influential reference
• Refractory generalized anxiety disorder.

  2009cited by this paper
• In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist

  2009cited by this paper
• Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells.

  2009cited by this paper
• Trait anxiety and impoverished prefrontal control of attention

  2009cited by this paper
• Selective gating of glutamatergic inputs to excitatory neurons of amygdala by presynaptic GABAb receptor.

  2009cited by this paper
• Emotion circuits in the brain.

  2009influential reference
• L-type voltage-dependent Ca2+ channels mediate expression of presynaptic LTP in amygdala

  2009cited by this paper
• 5-HT(1A) receptor function in major depressive disorder.

  2009cited by this paper
• Role of GABAA receptors in cognition.

  2009cited by this paper
• Post‐training excitotoxic lesions of the dorsal hippocampus attenuate generalization in auditory delay fear conditioning

  2009cited by this paper
• Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects

  2009influential reference
• Amygdala inhibitory circuits and the control of fear memory.

  2009influential reference
• Research in anxiety disorders: from the bench to the bedside.

  2009cited by this paper
• The complexity of the GABAA receptor shapes unique pharmacological profiles.

  2009cited by this paper
• A functional magnetic resonance imaging study of deliberate emotion regulation in resilience and posttraumatic stress disorder.

  2009influential reference
• Neural mechanisms of cognitive reappraisal of negative self-beliefs in social anxiety disorder.

  2009influential reference
• GABA A receptors: subtypes provide diversity of function and pharmacology.

  2009cited by this paper
• Amygdala intercalated neurons are required for expression of fear extinction

  2008cited by this paper
• Reversal of pathological pain through specific spinal GABAA receptor subtypes

  2008cited by this paper
• Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

  2008cited by this paper
• Dorsal hippocampus involvement in delay fear conditioning depends upon the strength of the tone‐footshock association

  2008cited by this paper
• Dopamine in amygdala gates limbic processing of aversive stimuli in humans

  2008cited by this paper
• Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations

  2008cited by this paper
• PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.

  2008cited by this paper
• Switching on and off fear by distinct neuronal circuits

  2008cited by this paper
• Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.

  2008influential reference
• A role for brain stress systems in addiction.

  2008cited by this paper
• RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors

  2008cited by this paper
• Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior

  2008cited by this paper
• Serotoninergic regulation of emotional and behavioural control processes.

  2008cited by this paper
• Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines

  2008cited by this paper
• In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist.

  2008cited by this paper
• Affective and cognitive effects of global deletion of &agr;3-containing gamma-aminobutyric acid-A receptors

  2008cited by this paper
• Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain

  2008cited by this paper
• Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.

  2008cited by this paper
• Behavioural neuroscience: The circuit of fear

  2008cited by this paper
• NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy

  2008cited by this paper
• The Modulation of Synaptic GABA A Receptors in the Thalamus by Eszopiclone and Zolpidem

  2008cited by this paper
• GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression

  2007cited by this paper
• Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptors

  2007cited by this paper
• Role of GABA in anxiety and depression

  2007cited by this paper
• GABAergic Control of Adult Hippocampal Neurogenesis in Relation to Behavior Indicative of Trait Anxiety and Depression States

  2007cited by this paper
• Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms.

  2007cited by this paper
• Norepinephrine enables the induction of associative long-term potentiation at thalamo-amygdala synapses

  2007cited by this paper
• GABA sets the tempo for activity-dependent adult neurogenesis.

  2007cited by this paper
• Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

  2007cited by this paper
• Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

  2007cited by this paper
• Neurocognitive mechanisms of anxiety: an integrative account.

  2007influential reference
• NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons

  2007cited by this paper
• Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist.

  2007cited by this paper
• The amygdala.

  2007cited by this paper
• Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.

  2007cited by this paper

• Differential GABA dynamics across brain functional networks in autism

  2026cites this paper
• The Virtual Brain links transcranial magnetic stimulation evoked potentials and inhibitory neurotransmitter changes in major depressive disorder

  2026cites this paper
• Gamma-aminobutyric acid associated research in Parkinson’s disease: an exploratory trends analysis

  2026cites this paper
• Plasma neurotransmitter-related metabolite alterations in adolescent major depressive disorder with and without psychotic features.

  2026cites this paper
• Alterations in Cortical Thickness in Anxiety Disorders and Their Association with Atlas-Based Neurotransmitter Maps.

  2026cites this paper
• Association between urinary neurotransmitter levels and the development of depressive symptoms in a general Japanese population: The Hisayama Study.

  2026cites this paper
• Medicinal plants for anxiety: Global evidence on species verified in the Philippine flora

  2026cites this paper
• Phytochemical screening, psychopharmacological and memory-cognitive potentiality of the Stephania japonica methanolic extract: In vivo and in silico approaches

  2026cites this paper
• Cell Type‐Specific Loss of SIRT1 in Central Amygdala Leads to Depression‐Like Behaviors by Altering Neuronal Excitability in Mice

  2026cites this paper
• Neuropeptide SP protects against colitis and linked anxiety-like behavior through the putative roles of gut microbiota and metabolite inositol

  2026cites this paper
• Safety, Sedative, and Anxiolytic Evaluation of MECS Hard Capsules Using In Silico and In Vivo Approaches

  2026cites this paper
• Examining the non-linear relationship between sugar consumption and anxiety symptoms in UK biobank data

  2026cites this paper
• Thalamic GABA+ levels are negatively associated with neuropsychiatric symptoms in patients with insomnia.

  2026cites this paper
• Venlafaxine combined with γ-aminobutyric acid exerted improved antidepressant and anxiolytic effects through modulating neurotransmitters and neuroplasticity.

  2026cites this paper
• Walnut peptide and theanine combination ameliorates sleep disorders: a multi-species study including a human trial.

  2026cites this paper
• Neuropharmacology of Neurotransmitter Systems: Current Drugs and Their Effects on Neural and Neuroendocrine Pathways

  2025cites this paper
• Mechanisms of Developmental Neurotoxicity of Dechlorane Plus, a Recently Identified Persistent Organic Pollutant: An In Silico Study.

  2025cites this paper
• Epigenetic markers of disease risk and psychotherapy response in anxiety disorders – a longitudinal analysis of the DNA methylome

  2025cites this paper
• Subanesthetic ketamine alters EEG signal complexity: Implications for treatment stratification in depression.

  2025cites this paper
• Neurotransmitter modulation of human facial emotion recognition

  2025cites this paper
• [Mechanism research progress of acupuncture for ameliorating pain-related emotions through regulating GABAergic system].

  2025cites this paper
• The neuropsychological profile of SSADH deficiency, a neurotransmitter disorder of GABA metabolism.

  2025cites this paper
• Ectoparasites enhance survival by suppressing host exploration and limiting dispersal

  2025cites this paper
• Impact of GABA and nutritional supplements on neurochemical biomarkers in autism: a PPA rodent model study

  2025cites this paper
• Gamma-aminobutyric acid A receptor alpha 4 in the nucleus accumbens mediates cue-induced heroin-seeking behavior in male rats via miR-7b.

  2025cites this paper
• Altered gut microbial functional pathways in people with irritable bowel syndrome enable precision health insights

  2025cites this paper
• Neuro-Inflammatory and Behavioral Changes Are Selectively Reversed by Sceletium tortuosum (Zembrin®) and Mesembrine in Male Rats Subjected to Unpredictable Chronic Mild Stress

  2025cites this paper
• The Impact of 5-Hydroxytryptophan Supplementation on Cognitive Function and Mood in Singapore Older Adults: A Randomized Controlled Trial

  2025cites this paper
• GABAergic and α-Glucosidase-Inhibitory Potentials of Fractions and Isolated Xanthones from Hypericum revolutum Vahl subsp. revolutum

  2025cites this paper
• The role of neuroactive steroids in psychiatric and neurological disorders: Neurobiology and therapeutic perspectives.

  2025cites this paper
• Neuropsychiatric Abnormalities in Metabolic Disturbances: Interplay of Adipokines and Neurotransmission

  2025cites this paper
• Development of a Guava Jelly Drink with Potential Antioxidant, Anti-Inflammation, Neurotransmitter, and Gut Microbiota Benefits

  2025cites this paper
• The shallow water test (SWT) as a novel behavioral paradigm to measure anxiety- and despair-like states in zebrafish.

  2025cites this paper
• Pyrazole in drug development: a medicinal-chemistry based analysis of USFDA-approved drugs in last decade

  2025cites this paper
• Cannabis-enriched oral Actinomyces induces anxiety-like behavior via impairing mitochondria and GABA signaling

  2025cites this paper
• Emerging Therapeutic Approaches and Drugs for Anxiety and Related Disorders

  2025cites this paper
• Sensory hyperacusis as a predictor of anxiety in adolescence.

  2025cites this paper
• Postbiotics as a Therapeutic Tool in Depression: Exploring into Molecular Pathways and Neuroprotective Effects.

  2025cites this paper
• Turning by-products into health: fermentation-driven production of bioactive compounds for cardiovascular disease prevention

  2025cites this paper
• microRNA-17-5p modulates ventral hippocampal transcriptome and synaptic proteome: Implications for emotional regulation in adult male rats.

  2025cites this paper
• Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants delta and omicron in human astrocytes

  2025cites this paper
• Detection of Pleiotropic Genetic Factors and Critical Brain Cell Types Linking Insomnia with Psychiatric Disorders.

  2025cites this paper
• Activation of zona incerta gamma-aminobutyric acid-ergic neurons alleviates depression-like and anxiety-like behaviors induced by chronic restraint stress

  2025cites this paper
• Chronic gut inflammation differentially modulates mitochondrial and antioxidant transcriptional programs in limbic brain structures

  2025cites this paper
• Chronic Pain and Comorbid Emotional Disorders: Neural Circuitry and Neuroimmunity Pathways

  2025cites this paper
• Genome-Wide Insights into Internalizing Symptoms in Admixed Latin American Children

  2025cites this paper
• Metabolomic analysis of bioactive compounds in dill (Anethum graveolens L.) extracts

  2025cites this paper
• Indomethacin Partially Alleviates Depressive‐Like Behaviors in Maternally Separated Mice: Targeting Neuroinflammatory Response in the Hippocampus

  2025cites this paper
• The interplay between thyrotropic axis, neurological complications, and rehabilitation outcomes in patients with traumatic brain injury.

  2025cites this paper
• Oregano essential oil enhanced body weight and well-being by modulating the HPA axis and 23-nordeoxycholic acid of cecal microbiota in Holstein steers under cold stress

  2025cites this paper
• Bacopa monnieri Extract Diminish Hypoxia-Induced Anxiety by Regulating HIF-1α Signaling and Enhancing the Antioxidant Defense System in Hippocampus

  2025cites this paper
• GABA TỪ ĐẬU XANH (Vigna radiata): BẰNG CHỨNG, CÔNG NGHỆ LÀM GIÀU VÀ LIÊN QUAN ĐẾN SỨC KHỎE THẦN KINH

  2025cites this paper
• Blood Microbiome Analysis Reveals Biomarkers of Treatment Response in Drug-Naïve Patients with First-Episode Psychosis: A Pilot Study

  2025cites this paper
• Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model

  2024cites this paper
• Young Adults with Anxiety Disorders Show Reduced Inhibition in the Dorsolateral Prefrontal Cortex at Higher Trait Anxiety Levels: A TMS-EEG Study

  2024cites this paper
• The bidirectional relationship of depression and disturbances in B cell homeostasis: Double trouble.

  2024cites this paper
• Preassembly of specific Gβγ subunits at GABAB receptors through auxiliary KCTD proteins accelerates channel gating.

  2024cites this paper
• Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care.

  2024cites this paper
• Germination in improving the nutrition, health benefits and processing of highland barley

  2024cites this paper
• An Evaluation of the Anxiolytic Potential of Amentoflavone in Adult Zebrafish Undergoing Alcohol Withdrawal: In Vivo and In Silico Studies

  2024cites this paper
• Gut microbiota connects the brain and the heart: potential mechanisms and clinical implications

  2024cites this paper
• Between neurons and networks: investigating mesoscale brain connectivity in neurological and psychiatric disorders

  2024cites this paper
• A review of the pharmacological action and mechanism of natural plant polysaccharides in depression

  2024cites this paper
• Synergistic effect between citalopram and muscimol upon induction of anxiolytic- and antidepressant-like effects in male mice: An isobologram analysis

  2024cites this paper
• Untargeted Plasma Metabolomic Profiling in Patients with Depressive Disorders: A Preliminary Study

  2024cites this paper
• Ketogenic diet and behavior: insights from experimental studies

  2024cites this paper
• Linalool, a Fragrance Compound in Plants, Protects Dopaminergic Neurons and Improves Motor Function and Skeletal Muscle Strength in Experimental Models of Parkinson’s Disease

  2024cites this paper
• GABA levels decline with age: A longitudinal study

  2024cites this paper
• Lactobacillus brevis-Fermented Gamma-Aminobutyric Acid Ameliorates Depression- and Anxiety-Like Behaviors by Activating the Brain-Derived Neurotrophic Factor-Tropomyosin Receptor Kinase B Signaling Pathway in BALB/C Mice.

  2024cites this paper
• Enhanced inhibitory effects of gamma-aminobutyric acid on renal and hepatic function, molecular profiles, and histological changes in male albino mice

  2024cites this paper
• Gamma-aminobutyric acid-enriched yogurt alleviates anxiety and memory decline in mice with circadian rhythm disorders via the gut-brain axis

  2024cites this paper
• Unveiling the anxiolytic and analgesic effects of citronellal in Swiss mice: in vivo and in silico insights into COX and GABAA receptor pathways

  2024cites this paper
• Exploring the Promise of Psychobiotics: Bridging Gut Microbiota and Mental Health for a Flourishing Society

  2024cites this paper
• Gut microbiome and metabolome library construction based on age group using short-read and long-read sequencing techniques in Korean traditional canine species Sapsaree

  2024cites this paper
• Uncovering the effects and mechanisms of tea and its components on depression, anxiety, and sleep disorders: A comprehensive review.

  2024cites this paper
• [Research progress of acupuncture in improving pain emotion by regulating functions of anterior cingulate cortex].

  2024cites this paper
• In Vitro Mechanistic Studies of a Standardized Sustainable Grape Seed Extract for Potential Application as a Mood-Modulating and Cognition-Enhancing Supplement

  2024cites this paper
• Cholecystokinin-expressing interneurons mediated inhibitory transmission and plasticity in basolateral amygdala modulate stress-induced anxiety-like behaviors in mice

  2024cites this paper
• Transcriptomic evidence of black soybean ethanolic extract and 2-aminobutyric acid in suppressing neuroinflammation and enhancing synaptic transmission.

  2024cites this paper
• Benzo[a]pyrene exposure induces anxiety-like behaviors in the mice through brain metabolic alterations.

  2024cites this paper
• Anxiolytic and sedative effects of sodium valproate with different experimental paradigms in male and female rats

  2024cites this paper
• Pathogenesis and therapeutic strategies for cancer-related depression.

  2024cites this paper
• GLYPHOSATE IMPAIRS BOTH STRUCTURE AND FUNCTION OF GABAERGIC SYNAPSES IN HIPPOCAMPAL NEURONS.

  2024cites this paper
• Luteolin and its antidepressant properties: From mechanism of action to potential therapeutic application

  2024cites this paper
• Regional homogeneity patterns reveal the genetic and neurobiological basis of State-Trait Anxiety

  2024cites this paper
• Antidepressant-like and Beneficial Effects of a Neoponcirin-Beta-Cyclodextrin Inclusion Complex in Mice Exposed to Prolonged Stress

  2024cites this paper
• Astrocytes in the Ventral Hippocampus Bidirectionally Regulate Innate and Stress‐Induced Anxiety‐Like Behaviors in Male Mice

  2024cites this paper
• Treatment response of venlafaxine induced alterations of gut microbiota and metabolites in a mouse model of depression

  2024cites this paper
• The association of physical activity and leisure-time sedentary behavior with perceived stress among Chinese adults: A cross-sectional study based on the Chinese health and nutrition survey data

  2024cites this paper
• Exploring the sedative properties of natural molecules from hop cones (Humulus lupulus) as promising natural anxiolytics through GABA receptors and the human serotonin transporter

  2024cites this paper
• The Challenges Experienced by ICU Nurses in Kuwait during the COVID-19 Pandemic

  2024cites this paper
• Role of Biosynthesis and Catabolism of Neurotransmitters in Drug Discovery for Anxiety and Depression.

  2024cites this paper
• Phenols and GABAA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae

  2024cites this paper
• Effects and neural mechanisms of different physical activity on major depressive disorder based on cerebral multimodality monitoring: a narrative review

  2024cites this paper
• The Ketogenic Diet as a Transdiagnostic Treatment for Neuropsychiatric Disorders: Mechanisms and Clinical Outcomes

  2024cites this paper
• Effect of parsley (Petroselinum crispum) extract on memory impairment and anxiety induced by immobilization stress in adult male rats

  2024cites this paper
• Accelerated Accumulation of γ-Aminobutyric Acid and Modifications on Its Metabolic Pathways in Black Rice Grains by Germination under Cold Stress

  2023cites this paper
• Effect of Fermentation on the Nutritional Quality of the Selected Vegetables and Legumes and Their Health Effects

  2023cites this paper
• Antidepressant Activities of Synthesized Benzodiazepine Analogues in Mice

  2023cites this paper
• The role of GPR39 zinc receptor in the modulation of glutamatergic and GABAergic transmission

  2023cites this paper